DEC-205—Targeted Antigen Delivery Enhances T Cell Immunity in a Murine Model of West Nile Virus Encephalitis 2260788
Targeted immunotherapies aimed at enhancing antiviral T cell responses are of particular interest for treating neurotropic viral infections such as West Nile Virus (WNV), which lacks a licensed human vaccine. Previous studies have shown that DEC-205+ dendritic cells (DCs) in the central nervous system (CNS) play...